← FDA DRUG APPROVALS

FDA ANDA · ANDA077839

ALBUTEROL SULFATE

Sponsor: RITEDOSE CORP

APPLICATION
ANDA077839
TYPE
ANDA
ORIGINAL APPROVAL
2008-12-16
LATEST ACTION
2013-01-28
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.083% BASE · SOLUTION · INHALATION

Approval history

2013-01-28Labeling · Supplement 13 · standardAP
2008-12-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →